Alan S Harris

Author:

Alan W. Harris

ISBN #:

0387293655

Author:

Alan Margetson Harris

ISBN #:

0950496707

Author:

Alan Edward Harris

ISBN #:

0090796705

Author:

Alan Edward Harris

ISBN #:

0090866207

Author:

Alan Edward Harris

ISBN #:

0435461893

Author:

Alan Edward Harris

ISBN #:

0470140860

Author:

Alan Harris

ISBN #:

0333589408

Author:

Alan Harris

ISBN #:

0333592808

US Patent:

6423721, Jul 23, 2002

Filed:

Sep 9, 1999

Appl. No.:

09/391795

Inventors:

Alan G. Harris - New York NY
Domenic G. Iezzoni - Ridgewood NJ
Melvyn R. Danzig - Morganville NJ
Richard R. Lorber - Scotch Plains NJ

Assignee:

Schering Corporation - Kenilworth NJ

International Classification:

A61K 3144

US Classification:

514290

Abstract:

The present invention discloses antibiotic-excluded compositions and methods to treat non-infective sinusitis and/or otitis media. The compositions comprise a therapeutically effective amount of an anticholinergic antihistamine or a pharmaceutically acceptable salt or solvate thereof; and (ii) a pharmaceutically acceptable carrier, and the methods comprise administering the same.

US Patent:

20020052388, May 2, 2002

Filed:

Oct 30, 2001

Appl. No.:

10/012920

Inventors:

Alan Harris - New York NY, US
Paul Medeiros - Easton PA, US

Assignee:

Schering Corporation

International Classification:

A61K031/473
A61K031/47

US Classification:

514/290000, 514/311000

Abstract:

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or cardiovascular disease by administrating an effective amount of loratadine, in combination with an effective amount of montelukast, for such treating and/or preventing are disclosed.

US Patent:

20020061902, May 23, 2002

Filed:

Oct 30, 2001

Appl. No.:

10/021189

Inventors:

Alan Harris - New York NY, US
Paul Medeiros - Easton PA, US

Assignee:

SCHERING CORPORATION

International Classification:

A61K031/496
A61K031/473

US Classification:

514/290000, 514/253030

Abstract:

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition of the skin or upper airway passages or cardiovascular disease by administrating an effective amount of an antihistamine, preferably desloratadine, alone, or in admixture with an effective amount of at least one leukotriene antagonist, preferably, montelukast, for such reducing and/or preventing are disclosed.

US Patent:

20040167150, Aug 26, 2004

Filed:

Mar 2, 2004

Appl. No.:

10/791477

Inventors:

Alan Harris - New York NY, US
Paul Medeiros - Easton PA, US

International Classification:

A61K031/473
A61K031/47

US Classification:

514/290000, 514/311000

Abstract:

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or cardiovascular disease by administrating an effective amount of loratadine, in combination with an effective amount of montelukast, for such treating and/or preventing are disclosed.

US Patent:

20060270697, Nov 30, 2006

Filed:

Aug 8, 2006

Appl. No.:

11/500651

Inventors:

Alan Harris - New York NY, US
Paul Medeiros - Easton PA, US

International Classification:

A61K 31/473

US Classification:

514290000

Abstract:

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or cardiovascular disease by administrating an effective amount of loratadine, in combination with an effective amount of montelukast, for such treating and/or preventing are disclosed.

US Patent:

20080269273, Oct 30, 2008

Filed:

Jun 30, 2008

Appl. No.:

12/165034

Inventors:

Alan G. Harris - New York NY, US
Paul T. Medeiros - Easton PA, US

International Classification:

A61K 31/444
A61P 9/00
A61P 37/08

US Classification:

514290

Abstract:

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or cardiovascular disease by administrating an effective amount of loratadine, in combination with an effective amount of montelukast, for such treating and/or preventing are disclosed.

US Patent:

20080299228, Dec 4, 2008

Filed:

May 29, 2008

Appl. No.:

12/129615

Inventors:

Alan Gerald Harris - New York NY, US
Keith Arthur Johnson - Durham NC, US
Tatjana Lukic - New York NY, US

International Classification:

A61K 38/29
A61P 17/00

US Classification:

424709, 514 12

Abstract:

Compositions, including those in which the active ingredient or agent is stable and capable of penetrating the sites of topical application are provided. The compositions can include a macromolecule, for example, a parathyroid hormone (PTH), a PTH-like hypercalcemic factor (CFF) or biologically active variant of a PTH or CFF in a vehicle comprising a polymer or cationic liposome. The compositions can also include other substances that further promote the stability of the active agent (e.g., buffers, antioxidants or carbohydrates). Also provided are methods for using the compositions for treatment of skin disorders (e.g., hyperproliferative skin disorders, including, but not limited to, for example, psoriasis, acne, rosacea or acne.)

US Patent:

20100160366, Jun 24, 2010

Filed:

Mar 9, 2010

Appl. No.:

12/720303

Inventors:

Alan G. Harris - New York NY, US
Paul T. Medeiros - Easton PA, US

International Classification:

A61K 31/435
A61P 9/00
A61P 11/06
A61P 11/00
A61P 37/08

US Classification:

514290

Abstract:

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or cardiovascular disease by administrating an effective amount of loratadine, in combination with an effective amount of montelukast, for such treating and/or preventing are disclosed.